A Patient with Bone Fragility, Multiple Fractures, Osteosarcoma, and the Variant c.143A>G in the IFITM5 Gene: A Case Report.
Harry PachajoaSebastian Giraldo-OcampoPublished in: Orthopedic research and reviews (2022)
Osteogenesis imperfecta (OI) is a group of genetic skeletal disorders, with a prevalence of 1 in 15,000-20,000 births. OI type V has been described in approximately 150 cases and all patients carry the variant (c.-14C> T) in the IFITM5 gene. However, two other variants, p.S40L and p.N48S have been reported in this gene, leading to clinical phenotypes different from OI type V. Here we described a patient with multiple bone fractures, scoliosis, skull alteration (plagiocephaly), bone deformation, bone rickets, and intramedullary epithelioid osteosarcoma that bears the recently reported heterozygous variant c.143A>G (p.N48S) in the IFITM5 gene. This case supports the pathogenicity of this new variant in the IFITM5 gene and adds information regarding its clinical phenotype.
Keyphrases
- copy number
- genome wide
- bone mineral density
- genome wide identification
- end stage renal disease
- bone regeneration
- case report
- soft tissue
- bone loss
- chronic kidney disease
- gene expression
- early onset
- dna methylation
- healthcare
- ejection fraction
- newly diagnosed
- postmenopausal women
- prognostic factors
- body composition
- peritoneal dialysis
- cystic fibrosis
- staphylococcus aureus
- genome wide analysis